Top

Published in:

01-09-2019 | Mastectomy | Review Article

Life Quality Index Assessment in Breast Cancer Patients

Authors: Sanjiv Srivastava, Alpana Srivastava, Sandeep Tiwari, Anand K. Mishra

Published in: Indian Journal of Surgical Oncology | Issue 3/2019

Abstract

Breast cancer (BC) is the most common cancer in Indian females whether they are from urban or rural area. Quality of life after treatment in BC patients is a very vital issue as its assessment will guide the clinicians, hospital authorities, and administrators to take appropriate steps to improve the delivery of treatment and address the concern. Improvement in QOL should be one of the ultimate aims of treatment in BC. The aim of this review is to collect and examine literature available on QOL in breast cancer patients and define what type of issues or domains should be studied. Four factors including chemotherapy treatment received by the patient, associated comorbidities, social support to patients from family, friends, support groups, and income of family have been found to have a strong association with QOL in BC patients/survivors. QOL assessment should include an instrument which assesses physical health, social health, psychological health, and spiritual health. There are less studies having all above domains so more studies are required for better understanding of QOL issue in BC patients/survivors.

Stewart BW, Paul Kleihues P (2003) World cancer report. Lyon, France, international agency research on cancer

Ferrans CE (1990) Development of a quality of life index for patients with cancer. Oncol Nurs Forum 17(3 Suppl):15–19 discussion 20–21PubMed

Moore FD, van de Vanter SB, Boyden CM, Lokich J, Wilson RE (1974) Adrenalectomy with chemotherapy in the treatment of advanced breast cancer: objective and subjective response rates, duration and quality of life. Surgery 76:376–390PubMed

Priestman TJ, Baum M (1976) Evaluation of quality of life in patients receiving treatment for advanced breast cancer. Lancet 1:899–900PubMed

Levine MN, Guyatt GH, Gent M, De Pauw S, Goodyear MD, Hryniuk WM, Arnold A, Findlay B, Skillings JR, Bramwell VH et al (1988) Quality of life in stage II breast cancer: an instrument for clinical trials. J Clin Oncol 6:1798–1810PubMed

Ciampi A, Lockwood G, Sutherland HJ, Llewellyn-Thomas HA (1988) Assessment of health related quality of life: factor scales for patients with breast cancer. J Psychsocial Oncol 6:1–19

Carlsson M, Hamrin E (1996) Measurement of quality of life in women with breast cancer. Development of a life satisfaction questionnaire (LSQ-32) and a comparison with the EORTC-C30. Qual Life Res 5:265–274PubMed

Sprangers MAG, Groenvold M, Arraras JI, Franklin J, teVelde A, Muller M, Franzini L, Williams A, de Haes HC, Hopwood P, Cull A, Aaronson NK (1996) The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field study. J Clin Oncol 14:2756–2768PubMed

Brady MJ, Cella DF, Mo F, Bonomi AE, Tulsky DS, Lloyd SR, Deasy S, Cobleigh M, Shiomoto G (1997) Reliability and validity of the functional assessment of cancer therapy breast quality of life instrument. J Clin Oncol 15:974–986PubMed

10.

Followfield LJ, Leaity SK, Howell A, Benson S, Cella D (1999) Assessment of quality of life in women undergoing hormonal therapy for breast cancer: validation of an endocrine symptom subscale for the FACT-B. Breast Cancer Res Treat 55:189–199

11.

Coster S, Poole K, Fallowfield LJ (2001) The validation of a quality of life scale to assess the impact of arm morbidity in breast cancer patients post-operatively. Breast Cancer Res Treat 68:273–282PubMed

12.

Carpenter JS (2001) The hot flash related daily interference scale: a tool for assessing the impact of hot flashes on quality of life following breast cancer. J Pain Symptom Manag 22:979–989

13.

Parmar V, Badwe RA, Hawaldar R, Rayabhattanavar S, Varghese A, Sharma R, Mittra I (2005) Validation of EORTC quality-of-life questionnaire in Indian women with operable breast cancer. Natl Med J India 18:172–177PubMed

14.

Avis NE, Foley KL (2006) Evaluation of the Quality of Life in Adult Cancer Survivors (QLACS) scale for long-term cancer survivors in a sample of breast cancer survivors. Health Qual Life Outcomes 4:92–102PubMedPubMedCentral

15.

Ganz PA, Schag CA, Lee JJ, Polinsy ML, Tan S (1992) Breast conservation versus mastectomy: is there a difference in psychological adjustment or quality of life in the year after surgery. Cancer 69:1729–1738PubMed

16.

Shimozuma K, Sonoo H, Ichihara K, Miyake K, Kurebayashi J, Ota K, Kiyono T (1995) The impact of breast conserving treatment and mastectomy on the quality of life in early-stage breast cancerpatients. Breast Cancer 2:35–43PubMed

17.

Curran D, van Dongen JP, Aaronson NK, Kiebert G, Fentiman IS, Mignolet F, Bartelink H (1998) Quality of life of early-stage breast cancerpatients treated with radical mastectomy or breast conservingprocedures: results of EORTC trial 10801. Eur J Cancer 34:307–314PubMed

18.

Shimozuma K, Ganz PA, Petersen L, Hirji K (1999) Quality of life in the first year after breast cancer surgery: rehabilitation needs and patterns of recovery. Breast Cancer Res Treat 56:45–57PubMed

19.

Kenny P, King MT, Sheill A, Seymour J, Hall J, Langlsnds A, Boyages J (2000) Early stage breast cancer, costs and quality of life one year after treatment by mastectomy or conservative surgery and radiation therapy. Breast 9:37–44PubMed

20.

Janni W, Rjosk D, Dimpfl T, Haertl K, Strobl B, Hepp F, Hanke A, Bergauer F, Sommer H (2001) Quality of life influenced by primary surgicaltreatment for stage I-III breast cancer-long term followupof a matched-pair analysis. Ann Surg Oncol 8:542–548PubMed

21.

Engel J, Kerr J, Schlesinger-Raab A, Sauer H, Halzel D (2004) Quality of life following breast-conserving therapy or mastectomy: results of a 5-year prospective study. Breast J 10:223–231PubMed

22.

Barranger E, Dubernard G, Fleurence J, Antoine M, Darai E, Uzan S (2005) Subjective morbidity and quality of life after sentinel node biopsy and axillary lymph node dissection for breast cancer. J Surg Oncol 92:17–22PubMed

23.

Pandey M, Thomas BC, Ramdas K, Ratheesan K (2006) Early effect of surgery on quality of life in women with operable breast cancer. Jap J Clin Oncol 36:468–472

24.

Kiebert GM, Hanneke J, de Haes CJ, Kievit J, van de Velde CJ (1990) Effectof peri-operative chemotherapy on the quality of life of patients with early breast cancer. Eur J Cancer 26:1038–1042PubMed

25.

Osoba D, Burchmore M (1999) Health-related quality of life in women with metastatic breast cancer treated with trastuzumab (Herceptin). Semin Oncol 26(4 Suppl 12):84–88PubMed

26.

Osoba D, Slamon DJ, Burchmore M, Murphy M (2002) Effects on quality of life of combined trastuzumab and chemotherapy in women with metastatic breast cancer. J Clin Oncol 20:3106–3113PubMed

27.

Bottomely A, Biganzoli L, Cufer T, Coleman RE, Coens C, Efficace F, Calvert HA, Gamucci T, Twelves C, Fargeot P, Piccart M (2004) Randomized controlled trial investigating short-term health-related quality of life with doxorubicin and paclitaxel versusdoxorubicin and cyclophosphamide as first-line chemotherapyin patients with metastatic breast cancer: European Organization for Research and Treatment of Cancer Breast Cancer Group, Investigational Drug Branch for Breast Cancer and the new drug development group study. J ClinOncol 22(13):2576–2586

28.

Martin M, Lluch A, Segui MA, Ruzi A, Ramos M, adrover E, Rodriguez-Lescure A, Grosse R, Calvo L, Fernandez-Chacon C, Roset M, Anton A, Isla D, del Prado PM, Iglesias L, Zaluski J, Arcusa A, Lopez-Vega JM, Munoz M, Mel JR (2006) Toxicity and health-related quality of life in breast patients receiving adjuvant docetaxel, doxorubicin, cyclophosphamide (TAC) or 5-fluorouracil, doxorubicin and cyclophosphamide (FAC): impact of adding primary prophylactic granulocyte-colony stimulating factor to the TAC regimen. Annal Oncol 17:1205–1212

29.

Fallowfield LJ, Bliss JM, Porter LS, Price MH, Snowdon CF, Jones SE, Coobes RC, Hall E (2006) Quality of life in the intergroup exemestanestudy: a randomized trial of exemestane versus continuedtamoxifen after 2 to 3 years of tamoxifen inpostmenopausal women with primary breast cancer. J Clin Oncol 24:910–917PubMed

30.

Cella D, Fallowfield L, Barker P, Cuzick J, Locker G, Howell A (2006) Quality of life of postmenopausal women in the ATAC (Arimidex, tamoxifen, alone or in combination) trial after completion of5 years' adjuvant treatment for early breast cancer. Breast Cancer Res Treat 100:273–284PubMed

31.

Karamouzis MV, Ioannidis G, Rigatos G (2007) Quality of life in metastatic breast cancer patients under chemotherapy or supportive care: a single-institution comparative study. Eur J Cancer Care 16:433–438

32.

Goodwin PJ, Ennis M, Bordeleau LJ, Pritchard KT, Trudeau ME, Koo J, Hood N (2004) Health-related quality of life and psychosocial statusin breast cancer prognosis: analysis of multiple variables. J Clin Oncol 22:4184–4192PubMed

33.

Efficace F, Therasse P, Piccart MJ, Coens C, van Steen K, Welnicka-Jaskiewicz M, Cufer T, Dyczka J, Lichinitser M, Shepherd L, de HH, Srangers MA, Bottomley A (2004) Health-related quality of life parameters as prognostic factors in a nonmetastatic breast cancer population: an international multicenter study. J Clin Oncol 22:3381–3388PubMed

34.

Coates A, Gebski V, Signorini D, Murray P, McNeil D, Byne M, Forbes JF (1992) Prognostic value of quality of life scores during chemotherapyfor advanced breast cancer. Australian New Zealand Breast Cancer Trial Group. J Clin Oncol 10:1833–1838PubMed

35.

Luoma ML, Hakamies-Blomqvist L, Sjostrom J, Pluzanska A, Ottoson S, Mouridsen H, Bengtsson NO, Bergh J, Malmstrom P, Valvere V, Tennvall L, Blomqvist C (2003) Prognostic value of quality of life scores for time to progression (TTP) and overall survival time (OS) in advanced breast cancer. Eur J Cancer 39:1370–1376PubMed

36.

Efficace F, Biganzoli L, Piccart M, Coens C, van Steen K, Cufer T, Coleman RE, Calvert HA, Gamucci T, Twelves C, Fargeot P, Bottomley A (2004) Baseline health-related quality of life data as prognostic factors in a phase III multicenter study of women with metastatic breast cancer. Eur J Cancer 40:1021–1030PubMed

37.

Hormes JM, Lytle LA, Gross CR, Ahmed RL, Troxel AB, Schmitz KH (2008) The body image and relationships scale: development and validation of a measure of body image in female breast cancer survivors. J Clin Oncol 26:1269–1274PubMed

38.

Schag CAC, Ganz PA, Heinrich RL (1991) Cancer rehabilitation evaluation system–short form (CARES-SF). Cancer 68:1406–1413PubMed

39.

McLachlan SA, Devins GM, Goodwin PJ (1998) Validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (QLQ-C30) as a measure of psychosocial function in breast cancer patients. Eur J Cancer 34:510–517PubMed

40.

Niezgoda HE, Pater JL (1993) A validation study of the domains of the core EORTC quality of life questionnaire. Qual Life Res 2:319–325

41.

Osoba D, Zee B, Pater J, Warr D, Kaizer L, Latreille J (1994) Psychometric properties and responsiveness of the EORTC quality of Life Questionnaire (QLQ-C30) in patients with breast, ovarian and lung cancer. Qual Life Res 3:353–364PubMed

42.

Ferrans CE (1990) Development of a quality of life index for patients with cancer. Oncol Nurs Forum 17:15–19PubMed

43.

Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A, Silberman M, Yellen SB, Winicour P, Brannon J, Eckberg K, Lloyd S, Purl S, Blendowski C, Goodman M, Barnicle M, Stewart I, McHale M, Bonomi P, Kaplan E, Taylor S IV, Thomas CR Jr, Harris J (1993) The functional assessment of cancer therapy scale: development and validation of the general measure. J Clin Oncol 11:570–579PubMed

44.

Peterman AH, Fitchett G, Brady MJ, Hernandez L, Cella D (2002) Measuring spiritual well-being in people with cancer: the functional assessment of chronic illness therapy-spiritual well-being scale (FACIT-Sp). Ann Behav Med 24:49–58PubMed

45.

Ferrell BR, Dow KH, Grant M (1995) Measurement of the quality of life in cancer survivors. Qual Life Res 4:523–531PubMed

46.

Dow KH, Ferrell BR, Leigh S, Ly J, Gulasekaram P (1996) An evaluation of the quality of life among long-term survivors of breast cancer. Breast Cancer Res Treat 39:261–273PubMed

47.

Sammarco A (2003) Quality of life among older survivors of breast cancer. Cancer Nurs 26:431–438PubMed

48.

Perkins EA, Small BJ, Balducci L, Extermann M, Robb C, Haley WE (2007) Individual differences in well-being in older breast cancer survivors. Crit Rev Oncol Hematol 62:74–83PubMedPubMedCentral

49.

Leak A, Hu J, King CR (2008) Symptom distress, spirituality, and quality of life in African American breast cancer survivors. Cancer Nurs 31:E15–E21PubMed

50.

Sammarco A, Konecny LM (2008) Quality of life, social support, and uncertainty among Latina breast cancer survivors. Oncol Nurs Forum 35:844–849PubMed

51.

Cimprich B, Ronis DL, Martinez-Ramos G (2002) Age at diagnosis and quality of life in breast cancer survivors. Cancer Pract 10:85–93PubMed

Title: Life Quality Index Assessment in Breast Cancer Patients
Authors: Sanjiv Srivastava
Alpana Srivastava
Sandeep Tiwari
Anand K. Mishra
Publication date: 01-09-2019
Publisher: Springer India
Keywords: Mastectomy
Breast Cancer
Breast Cancer
Cytostatic Therapy
Published in: Indian Journal of Surgical Oncology / Issue 3/2019
Print ISSN: 0975-7651
Electronic ISSN: 0976-6952
DOI: https://doi.org/10.1007/s13193-019-00923-8

At a glance: The STEP trials

Springer Medicine

Life Quality Index Assessment in Breast Cancer Patients

Abstract

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2019

Editorial

Can Preoperative Ultrasonography and MRI Replace Sentinel Lymph Node Biopsy in Management of Axilla in Early Breast Cancer—a Prospective Study from a Tertiary Cancer Center

Oophorectomy as a Hormonal Ablation Therapy in Metastatic and Recurrent Breast Cancer: Current Indications and Results

Unusual Complication After TTE: a Simple Management

Evaluation of Computed Tomography Scan and CA 125 Response in Predicting Operability in Advanced Ovarian Cancer and Assessing Survival Outcome in Interval Cytoreductive Surgery

Cutaneous Metastasis of Laryngeal Neuroendocrine Carcinoma: a Case Report